covid 19 News and Research

RSS

Vaccination against pertussis in pregnancy and outstanding scientific questions

A recent paper published in Vaccines summarized the data presented and the discussions in the meeting regarding pertussis vaccination in pregnancy (ViP).

2 Dec 2022

The effect of ubiquitination on SARS-CoV-2 infection and patient prognosis

A recent Clinical and Translational Medicine study utilized several published public datasets to evaluate the biological characteristics associated with the ubiquitination of patients infected with SARS-CoV-2.

2 Dec 2022

The prevalence and risk factors of pediatric post-COVID in a population-based sample

Researchers compared seropositive and seronegative children between the ages of six months and 17 years to assess the risk factors and prevalence of persistent symptoms of post-COVID syndrome.

2 Dec 2022

Antibody responses engendered by maternal SARS-CoV-2 vaccination following initial and booster doses in maternal circulation and breastmilk

Researchers investigated passive immunization of the fetus and neonates by evaluating the antibody responses elicited by primary and booster doses of maternal SARS-CoV-2 vaccination.

2 Dec 2022

Collaborative work unravels hidden molecular secrets of age-related diseases

Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, and the University of Copenhagen announced today the release of the first batch of results from the collaborative work directed to perform multi-omics-based analyses in the context of age-related diseases using an AI-driven target and drug discovery pipeline.

2 Dec 2022

New report shows increase in mental disorder rates among 17 to 19 year olds in 2022

One in four 17 to 19 year olds in England had a probable mental disorder in 2022 – an increase from one in six in 2021.

2 Dec 2022

The business of clinical trials is booming. Private equity has taken notice.

After finding success investing in the more obviously lucrative corners of American medicine — like surgery centers and dermatology practices — private equity firms have moved aggressively into the industry's more hidden niches: They are pouring billions into the business of clinical drug trials.

2 Dec 2022

Study reveals the widespread impact of pandemic on long COVID patients and people with other illnesses

Long COVID patients can experience many of the same lingering negative effects on their physical, mental, and social well-being as those experienced by people who become ill with other, non-COVID illnesses, new research suggests.

1 Dec 2022

Primary and original booster mRNA vaccination can reduce the risk of Omicron-related infection

mRNA COVID-19 vaccines are less effective against Omicron infections than other variants. A study publishing December 1st in the open access journal PLOS Medicine by Margaret L. Lind at the Yale School of Public Health, U.S. and colleagues suggests that the additional protection offered by the initial booster shot may be reduced among people with a previous COVID-19 infection.

1 Dec 2022

Best practices and challenges in One Health approach to fight zoonotic diseases

Announcing a new article publication for Zoonoses journal. Zoonoses are infectious diseases that can be transmitted from animals to humans and/or from humans to animals.

1 Dec 2022

LSHTM researchers launch new global health research group on HIV-associated fungal infections

Researchers from the London School of Hygiene & Tropical Medicine are co-launching a new global health research group on HIV-associated fungal infections.

1 Dec 2022

Gargling with povidone-iodine may reduce salivary viral load in COVID-19 patients

A prospective, randomized, open-level clinical trial demonstrates that gargling with povidone-iodine accelerates viral clearance and reduces saliva infectivity in patients with asymptomatic or mild coronavirus disease 2019 (COVID-19). The trial findings have been published in the journal Scientific Reports.

1 Dec 2022

Human T cell immunity is coping with mutations in SARS-CoV-2 variants of concern

Immune T cells are continuing to target the spike protein of SARS-CoV-2 variants of concern, although mutations are making some T cells less effective, according to new research.

1 Dec 2022

Prior infection and vaccination protects against severe outcomes from SARS-CoV-2 Omicron infection

Previous infection with SARS-CoV-2 and booster vaccination protect against ICU admission and mortality following infection with the Omicron variant.

1 Dec 2022

New metagenomic study reveals global landscape of antimicrobial resistance

There are large geographical differences in both how frequently resistant genes occur and in which types of bacteria the genes are found.

1 Dec 2022

COVID-19 infection may lead to long-term liver injury

COVID-19 infection is associated with increased liver stiffness, a sign of possible long-term liver injury, according to the results of a new study being presented today at the annual meeting of the Radiological Society of North America.

1 Dec 2022

Study shows only 75.8% of children under 15 have antibodies against measles

A study conducted in Brazil and reported in an article in Vaccines shows that in the São José do Rio Preto region in the northwest of São Paulo state, only 75.8% of children aged 0-15 have antibodies against measles.

1 Dec 2022

Pandemic-related stressors have physically altered teens’ brains, study shows

A new study from Stanford University suggests that pandemic-related stressors have physically altered adolescents' brains, making their brain structures appear several years older than the brains of comparable peers before the pandemic.

1 Dec 2022

KHN’s ‘What the Health?’: Medicaid machinations

The lame-duck Congress is back in Washington with a long list of bills it would like to pass and a short time to do it before Republicans take over the House majority in January.

1 Dec 2022

Risk factor assessment for the development of severe SARS-CoV-2 breakthrough infections

researchers evaluated the severity of breakthrough SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infections and the risk factors associated with severity among individuals vaccinated for coronavirus disease 2019 (COVID-19) in Sousse, Tunisia.

1 Dec 2022

covid 19 News and Research

Vaccination against pertussis in pregnancy and outstanding scientific questions

The effect of ubiquitination on SARS-CoV-2 infection and patient prognosis

The prevalence and risk factors of pediatric post-COVID in a population-based sample

Antibody responses engendered by maternal SARS-CoV-2 vaccination following initial and booster doses in maternal circulation and breastmilk

Collaborative work unravels hidden molecular secrets of age-related diseases

New report shows increase in mental disorder rates among 17 to 19 year olds in 2022

The business of clinical trials is booming. Private equity has taken notice.

Study reveals the widespread impact of pandemic on long COVID patients and people with other illnesses

Primary and original booster mRNA vaccination can reduce the risk of Omicron-related infection

Best practices and challenges in One Health approach to fight zoonotic diseases

LSHTM researchers launch new global health research group on HIV-associated fungal infections

Gargling with povidone-iodine may reduce salivary viral load in COVID-19 patients

Human T cell immunity is coping with mutations in SARS-CoV-2 variants of concern

Prior infection and vaccination protects against severe outcomes from SARS-CoV-2 Omicron infection

New metagenomic study reveals global landscape of antimicrobial resistance

COVID-19 infection may lead to long-term liver injury

Study shows only 75.8% of children under 15 have antibodies against measles

Pandemic-related stressors have physically altered teens’ brains, study shows

KHN’s ‘What the Health?’: Medicaid machinations

Risk factor assessment for the development of severe SARS-CoV-2 breakthrough infections

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News